Ipragliflozin lowers small, dense low-density lipoprotein cholesterol levels in japanese patients with type 2 diabetes mellitus

Highlights • Small dense LDL-C (sd LDL-C) convey cardiovascular risk in type 2 diabetes (T2D). • Ipragliflozin reduced sd LDL-C levels in Japanese patients with T2D. • Changes in body weight, TG and LDL-C levels contributed to sd LDL-C reduction.

Saved in:

Bibliographic Details
Published in:	Journal of clinical & translational endocrinology Vol. 6; no. C; pp. 1 - 7
Main Authors:	Bando, Yukihiro, Tohyama, Hitomi, Aoki, Keiko, Kanehara, Hideo, Hisada, Azusa, Okafuji, Kazuhiro, Toya, Daisyu
Format:	Journal Article
Language:	English
Published:	Netherlands Elsevier Inc 01-12-2016 Elsevier
Subjects:	Endocrinology & Metabolism Ipragliflozin Research Paper Small dense LDL cholesterol Type 2 diabetes mellitus small dense LDL cholesterol Type 2 diabetes mellitus Ipragliflozin Small dense LDL cholesterol
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Highlights • Small dense LDL-C (sd LDL-C) convey cardiovascular risk in type 2 diabetes (T2D). • Ipragliflozin reduced sd LDL-C levels in Japanese patients with T2D. • Changes in body weight, TG and LDL-C levels contributed to sd LDL-C reduction.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	2214-6237 2214-6237
DOI:	10.1016/j.jcte.2016.06.001